Dr Reddys Laboratories Ltd

Dr Reddy's Labs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Dr Reddys Laboratories Ltd

₹ 1,251 -2.99%
29 Oct - close price
drreddys.com BSE: 500124 NSE: DRREDDY
About

Dr. Reddy's Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations.

Key Points

Global Generics Segment (~83% of revenues in FY22)
Co. offers 400+ high-quality generic drugs, keeping costs reasonable by leveraging its integrated operations. The company benefits from its expertise in active ingredients, product development skills, a keen understanding of regulations and intellectual property rights & streamlined supply chain. [1]
Top revenue contributors of the segment are nervous system drugs (14%), gastrointestinal (13%) & anti-infective (10%) [2]
In FY22, co. filed 7 new ANDA’s with US FDA [3]

Website BSE NSE
  • Market Cap ₹ 1,04,313 Cr.
  • Current Price ₹ 1,251
  • High / Low ₹ 1,406 / 1,020
  • Stock P/E 18.1
  • Book Value ₹ 432
  • Dividend Yield 0.64 %
  • ROCE 22.7 %
  • ROE 18.0 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has delivered good profit growth of 22.3% CAGR over last 5 years
  • Company's working capital requirements have reduced from 90.5 days to 69.2 days

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of Nifty 50 BSE 500 BSE Healthcare BSE 100 BSE 200

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
6,332 6,790 6,315 6,758 6,903 7,237 7,114 7,696 8,038 8,381 8,528 8,572 8,828
4,433 4,851 4,781 4,696 4,894 5,214 5,283 5,566 5,962 6,108 6,530 6,398 6,818
Operating Profit 1,899 1,939 1,534 2,062 2,008 2,023 1,831 2,130 2,076 2,273 1,998 2,174 2,010
OPM % 30% 29% 24% 31% 29% 28% 26% 28% 26% 27% 23% 25% 23%
55 65 146 178 319 219 201 193 314 154 528 290 330
Interest 31 42 35 37 35 39 59 60 76 82 66 83 91
Depreciation 309 324 316 353 376 374 368 381 397 471 455 476 505
Profit before tax 1,614 1,638 1,329 1,850 1,917 1,829 1,605 1,883 1,917 1,874 2,005 1,905 1,745
Tax % 31% 24% 28% 24% 23% 24% 18% 26% 30% 25% 21% 26% 23%
1,114 1,244 960 1,405 1,482 1,381 1,310 1,392 1,342 1,404 1,587 1,410 1,337
EPS in Rs 13.39 14.94 11.53 16.87 17.77 16.56 15.70 16.69 15.05 16.94 19.09 16.99 16.14
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
13,415 15,023 15,568 14,196 14,281 15,448 17,517 19,048 21,545 24,670 28,011 32,644 34,310
10,164 11,515 11,983 11,724 11,930 12,270 15,040 15,173 17,778 18,200 20,078 24,097 25,856
Operating Profit 3,251 3,508 3,585 2,472 2,351 3,178 2,477 3,874 3,768 6,470 7,933 8,547 8,454
OPM % 24% 23% 23% 17% 16% 21% 14% 20% 17% 26% 28% 26% 25%
170 260 295 172 155 381 670 335 555 971 909 1,119 1,303
Interest 127 108 83 63 79 89 98 97 96 143 171 283 321
Depreciation 648 760 939 1,027 1,077 1,135 1,163 1,229 1,165 1,250 1,470 1,704 1,907
Profit before tax 2,646 2,900 2,859 1,554 1,350 2,336 1,886 2,884 3,061 6,048 7,201 7,680 7,529
Tax % 26% 19% 26% 19% 32% 17% -7% 32% 29% 25% 23% 25%
1,963 2,336 2,131 1,292 947 1,950 2,026 1,952 2,182 4,507 5,578 5,725 5,738
EPS in Rs 23.08 27.43 24.98 15.59 11.41 23.49 24.38 23.47 26.23 54.14 66.87 67.77 69.16
Dividend Payout % 16% 15% 16% 26% 35% 17% 21% 21% 23% 15% 12% 12%
Compounded Sales Growth
10 Years: 8%
5 Years: 13%
3 Years: 15%
TTM: 14%
Compounded Profit Growth
10 Years: 9%
5 Years: 22%
3 Years: 38%
TTM: 8%
Stock Price CAGR
10 Years: 4%
5 Years: 5%
3 Years: 12%
1 Year: -2%
Return on Equity
10 Years: 16%
5 Years: 17%
3 Years: 20%
Last Year: 18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 85 85 85 83 83 83 83 83 83 83 83 83 84
Reserves 7,780 9,768 12,484 12,179 12,489 13,941 15,516 17,558 19,129 23,203 28,171 33,466 35,930
4,477 4,314 3,352 4,918 5,071 3,838 2,210 3,031 3,384 1,347 2,002 4,677 5,854
3,563 4,290 4,408 4,474 4,706 4,557 5,414 5,915 7,149 7,576 8,523 9,797 12,505
Total Liabilities 15,906 18,457 20,330 21,654 22,349 22,418 23,223 26,588 29,746 32,209 38,780 48,023 54,373
4,641 5,377 6,563 6,931 6,968 7,191 6,850 8,206 8,122 9,219 10,426 18,226 20,617
CWIP 639 529 772 3,324 3,470 2,934 1,535 1,565 1,293 1,030 1,419 2,466 1,997
Investments 1,067 2,248 3,833 2,110 2,298 2,587 2,678 2,212 2,616 4,986 4,930 4,051 4,701
9,559 10,303 9,162 9,290 9,612 9,707 12,160 14,605 17,715 16,974 22,004 23,280 27,058
Total Assets 15,906 18,457 20,330 21,654 22,349 22,418 23,223 26,588 29,746 32,209 38,780 48,023 54,373

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1,970 2,524 3,263 2,144 1,803 2,870 2,984 3,570 2,811 5,888 4,543 4,643
-1,604 -2,370 -1,610 -1,890 -1,483 -769 -495 -2,255 -2,565 -4,109 -4,034 -5,785
-24 -433 -1,700 -369 -444 -2,133 -2,516 -30 -242 -2,686 -376 1,891
Net Cash Flow 342 -280 -47 -114 -124 -31 -27 1,286 3 -907 133 749

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 90 100 97 98 104 94 105 95 113 107 105 101
Inventory Days 271 248 248 282 263 273 230 273 250 232 283 260
Days Payable 100 84 88 104 121 111 100 109 111 108 116 97
Cash Conversion Cycle 261 264 257 275 246 256 235 259 252 231 271 264
Working Capital Days 32 26 34 -14 39 65 59 57 61 84 118 69
ROCE % 25% 22% 19% 9% 8% 13% 11% 16% 14% 27% 27% 23%

Shareholding Pattern

Numbers in percentages

3 Recently
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
26.69% 26.69% 26.69% 26.66% 26.65% 26.65% 26.65% 26.64% 26.64% 26.64% 26.64% 26.64%
27.29% 27.25% 26.99% 28.19% 28.62% 29.13% 27.68% 27.53% 26.85% 25.75% 25.33% 24.69%
23.38% 23.05% 21.99% 21.04% 18.65% 18.31% 20.72% 21.48% 22.89% 25.63% 26.73% 27.99%
22.36% 22.78% 24.11% 23.93% 25.89% 25.73% 24.78% 24.20% 23.46% 21.69% 21.04% 20.45%
0.25% 0.22% 0.21% 0.18% 0.18% 0.17% 0.17% 0.16% 0.16% 0.29% 0.26% 0.25%
No. of Shareholders 2,46,7882,32,7152,46,7692,43,4452,57,7942,55,5002,67,6943,10,4034,03,6694,59,6054,51,9294,49,216

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls